Patents by Inventor Timothy E. Benson

Timothy E. Benson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7806980
    Abstract: An inhibitor bound form of human beta secretase, also known as memapsin 2 and BACE, particularly in a glycosylated form as expressed in Chinese hamster ovary (CHO), HEK293 cells, or in insect cells as part of a Baculovirus expression system has been crystallized, and the three dimensional x-ray crystal structure has been solved to 3.2 ? resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of human beta secretase activity.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: October 5, 2010
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Timothy E. Benson, Jim D. Durbin, D. Bryan Prince
  • Publication number: 20100112665
    Abstract: An inhibitor bound form of human beta secretase, also known as memapsin 2 and BACE, particularly in a glycosylated form as expressed in Chinese hamster ovary (CHO), HEK293 cells, or in insect cells as part of a Baculovirus expression system has been crystallized, and the three dimensional x-ray crystal structure has been solved to 3.2 ? resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of human beta secretase activity.
    Type: Application
    Filed: September 2, 2009
    Publication date: May 6, 2010
    Inventors: Timothy E. Benson, Jim D. Durbin, D. Bryan Prince
  • Patent number: 7601528
    Abstract: An inhibitor bound form of human beta secretase, also known as memapsin 2 and BACE, particularly in a glycosylated form as expressed in Chinese hamster ovary (CHO), HEK293 cells, or in insect cells as part of a Baculovirus expression system has been crystallized, and the three dimensional x-ray crystal structure has been solved to 3.2 ? resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of human beta secretase activity.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: October 13, 2009
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Timothy E. Benson, Jim D. Durbin, D. Bryan Prince
  • Publication number: 20090125289
    Abstract: An inhibitor bound form of human beta secretase, also known as memapsin 2 and BACE, particularly in a glycosylated form as expressed in Chinese hamster ovary (CHO), HEK293 cells, or in insect cells as part of a Baculovirus expression system has been crystallized, and the three-dimensional x-ray crystal structure has been solved to 3.2 ? resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of human beta secretase activity.
    Type: Application
    Filed: May 14, 2007
    Publication date: May 14, 2009
    Inventors: Timothy E. Benson, Jim D. Durbin, Donald Bryan Prince
  • Patent number: 7524668
    Abstract: The present invention provides a crystal of human beta-secretase (BACE) having monoclinic space group symmetry C2, in a representative example, comprising a unit cell having dimensions of a, b, and c, wherein a is about 53 ? to about 103 ?, b is about 85 ? to about 125 ?, c is about 40 ? to about 60 ?, and ?=?=90°, and ? is about 85° to about 105°, and in a preferred example, comprising unit cell dimensions as follows: a is 73.1 ?, b is 105.1 ?, c is 50.5 ?, and ?=?=90°, and ? is 94.8, wherein the Matthews coefficient of said crystal is 2.1 ?/Da with 42% solvent, and wherein said crystal diffracts to 1.7 ? resolution.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: April 28, 2009
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Timothy E. Benson, D. Danielle Woods, Donald Bryan Prince
  • Patent number: 7442537
    Abstract: The x-ray crystal structure of BACE or BACE-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing potential modifiers of BACE activity.
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: October 28, 2008
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Timothy E. Benson, Daisy Danielle Woods, Donald Bryan Prince
  • Publication number: 20080215249
    Abstract: The x-ray crystal structure of human BACE or BACE-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing potential modifiers of human BACE activity.
    Type: Application
    Filed: April 16, 2008
    Publication date: September 4, 2008
    Inventors: Timothy E. Benson, Jim D. Durbin, Thomas L. Emmons, Alfredo G. Tomasselli
  • Patent number: 7384773
    Abstract: The x-ray crystal structure of human BACE or BACE-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing potential modifiers of human BACE activity.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: June 10, 2008
    Assignee: Pfizer Inc
    Inventors: Timothy E. Benson, Jim D. Durbin, Thomas L. Emmons, Alfredo G. Tomasselli
  • Patent number: 7217556
    Abstract: The x-ray crystal structure of BACE or BACE-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing potential modifiers of BACE activity.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: May 15, 2007
    Assignee: Pfizer Inc
    Inventors: Timothy E. Benson, Jim D. Durbin, Donald Bryan Prince
  • Patent number: 6988041
    Abstract: An unliganded form of Staphylococcus aureus NAD synthetase (S. aureus NadE) has been crystallized, and the three-dimensional x-ray crystal structure has been solved to 2.3 ? resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus NadE activity.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: January 17, 2006
    Assignee: Pharmacia & Upjohn Company
    Inventors: Timothy E. Benson, Donald Bryan Prince
  • Publication number: 20040171050
    Abstract: An unliganded form of Staphylococcus aureus thymidylate kinase (S. aureus TMK) has been crystallized, and the three dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus TMK activity.
    Type: Application
    Filed: January 8, 2004
    Publication date: September 2, 2004
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventor: Timothy E. Benson
  • Patent number: 6689595
    Abstract: An unliganded form of Staphylococcus aureus thymidylate kinase (S. aureus TMK) has been crystallized, and the three dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus TMK activity.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: February 10, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventor: Timothy E. Benson
  • Publication number: 20030166843
    Abstract: An unliganded form of Staphylococcus aureus thioredoxin reductase (S. aureus TrxB) has been crystallized, and the three dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus thioredoxin reductase.
    Type: Application
    Filed: April 3, 2001
    Publication date: September 4, 2003
    Inventor: Timothy E. Benson
  • Publication number: 20030166233
    Abstract: An unliganded form of Staphylococcus aureus NAD synthetase (S. aureus NadE) has been crystallized, and the three-dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus NadE activity.
    Type: Application
    Filed: January 30, 2001
    Publication date: September 4, 2003
    Inventors: Timothy E. Benson, Donald Bryan Prince
  • Publication number: 20020156585
    Abstract: The substrate free form of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) has been crystallized, and the three dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus MurB.
    Type: Application
    Filed: November 21, 2001
    Publication date: October 24, 2002
    Applicant: Pharmacia & Upjohn Company
    Inventor: Timothy E. Benson
  • Publication number: 20020072105
    Abstract: The x-ray crystal structure of FemA and/or FemA-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing modifiers of FemA activity.
    Type: Application
    Filed: August 17, 2001
    Publication date: June 13, 2002
    Inventors: Timothy E. Benson, Donald Bryan Prince
  • Patent number: 6356845
    Abstract: The substrate free form of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) has been crystallized, and the three dimensional x-ray crystal structure has been solved to 2.3 Å resolution. The x-ray crystal structure is useful for solving the structure of other molecules or molecular complexes, and designing inhibitors of S. aureus MurB.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: March 12, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Timothy E. Benson, Melissa S. Harris